Forvard P/S multiplikatori: Integra LifeSciences Holdings Corporation (IART)
Neyroxirurgiya sohasida yuqori narx belgilash imkoniyatiga ega bo'lgan Integra LifeSciences (IART) vaqtincha tartibga soluvchi cheklovlar bilan to'qnash keldi. Metrika darajasi 0.00 bo'lgan prognoz qilingan P/S koeffitsiyenti narxlarning tiklanish imkoniyatlarini baholashga yordam beradi. Barqaror pul oqimi sarflanadigan materiallarga bo'lgan doimiy talab bilan ta'minlanmoqda, o'sish potentsiali esa ishlab chiqarish quvvatlarining qayta ishga tushirilishi va strategik sotib olishlarga asoslangan.
Integra LifeSciences Inc. (IART) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Integra LifeSciences|IART - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Integra LifeSciences|IART - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Integra LifeSciences Inc.|IART - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Integra LifeSciences|Tezkor likvidlik koeffitsiyenti integralife.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
IART - Kompaniyaning sof daromadi|Kutilayotgan foyda Integra LifeSciences|IART - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Prognoz qilingan narxning foydaga nisbati Integra|IART - PEG multiplikatori|EV/EBITDA multiplikatori Integra LifeSciences Inc.|IART - Amortizatsiya chegirilmasdan oldingi operatsion daromad|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Integra LifeSciences|IART - So'nggi 12 oy davomida bitta aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi integralife.com|IART - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Integra LifeSciences
- sotuvlar va tushum ko'rsatkichlari:
Kompaniyaning fundamental tahlili:IART (Integra LifeSciences Holdings Corporation)
Emitent ishonchliligini tekshirishda, kutilayotgan savdo hajmi nisbatidagi bozor qiymatini baholash juda muhimdir. Forward P/S ko'rsatkichi joriy bozor kapitalizatsiyasining prognoz qilingan daromadga nisbati sifatida hisoblanadi, bu esa qisqa muddatli kotirovkalarning tebranishlarini bartaraf etadi. Integra LifeSciences (IART) uchun ushbu nisbat biomateriallar ishlab chiquvchilarini sotib olish va neyroxirurgiya hamkorliklaridan kelib chiqadigan sinergiyaning bozor stavkasini aks ettiradi. GURU.Markets platformasidagi forward P/S ko'rsatkichi tendentsiyasi real biznes o'sishini spekulyativ likvidlik oqimlaridan farqlash imkonini beradi.
Integra LifeSciences kimlar bilan raqobatlashadi
Narxning prognoz qilingan daromadga nisbati Boston Scientific Corporation BSX|EW - Forvard narx/daromad multiplikatori|ResMed Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Insulet Inc.|ZBH: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati COO|ALGN (Align Technology) - Forvard P/S multiplikatori|Globus Medical Inc (GMED) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori TMDX|Forvard narx/daromad multiplikatori Alphatec Corp ATEC|Forvard P/S multiplikatori AORT (Artivion, Inc.)|Forvard P/S multiplikatori enovis.com ENOV|ESTA - Narxning prognoz qilingan daromadga nisbati|BBNX: Narxning prognoz qilingan daromadga nisbati|IRMD (Iradimed) - Forvard narx/daromad multiplikatori|Embecta Health - Sotuvga nisbatan forvard narx|TNDM (Tandem Diabetes Care) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati axogeninc.com AXGN|Narxning prognoz qilingan daromadga nisbati SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prognoz narxning daromadga nisbati|Bioventus Corp - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori OrthoPediatrics Corp KIDS|Treace Medical Concepts - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati blade.com SRTA|Carlsmed (CARL) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati RXST (RxSight Inc)|Narxning prognoz qilingan daromadga nisbati ClearPoint Neuro Inc.|Forvard narx/daromad multiplikatori Stereotaxis Corporation (STXS)|Forvard P/S multiplikatori STIM|SGHT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Orchestra BioMed, Inc. OBIO|ANIK: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|NSPR: Forvard narx/daromad multiplikatori|Jin Medical International - Narxning kutilayotgan daromadga nisbati|VANI: Forvard P/S multiplikatori|XTNT - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati NeuroOne Medical Technologies Corporation|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODD (Modular Med)|Forvard narx/daromad multiplikatori MYO (Myomo, Inc)|Narxning kutilayotgan daromadga nisbati COCH|Forvard P/S multiplikatori VVOS (Vivos Therapeutics)|envveno.com (NVNO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SINTX Technologies - Forvard P/S multiplikatori|Prognoz narxning daromadga nisbati Tenon Medical Inc. (TNON)|ReWalk Robotics Ltd (LFWD) - Narxning prognoz qilingan daromadga nisbati|Autonomix Medical - Sotuvga nisbatan forvard narx|IVF (INVO Fertility Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori bonebiologics.com|Forvard narx/daromad multiplikatori AXNX (Axonics)|BIOL (BIOLASE Inc.) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Dynatronics DYNT|Paragon 28 Inc. - Narxning prognoz qilingan daromadga nisbati|INVO Bio - Forvard P/S multiplikatori
